STING1 and metabolic dysfunction-associated steatotic liver disease: Since the relative expression of STING was increased at the SS stage of NAFLD in hepatic tissue from women with MO, the steatosis parameter was used to categorize patients into four groups according to severity: absence, mild, moderate, and severe.